Elanco Animal Health (ELAN) Interest Coverage Ratio (2018 - 2026)
Elanco Animal Health (ELAN) reported Interest Coverage Ratio of 5.11 for Q1 2026, down 14.91% on a YoY basis from 6.0 in Q1 2025, and up 1028.23% sequentially from 0.55 in Q4 2025.
Elanco Animal Health (ELAN) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 9 years of Interest Coverage Ratio data on file, last reported at 5.11 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 14.91% year-over-year to 5.11; the trailing twelve-month figure through Mar 2026 stood at 2.66 (up 193.01% YoY), and the FY2025 full-year result was 2.54, up 149.56% from the prior year.
- Interest Coverage Ratio climbed to 5.11 in Q1 2026, from 0.55 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 6.0 in Q1 2025 to a low of 22.0 in Q3 2023.
- A 5-year average of 4.18 and a median of 5.56 in 2022 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio plunged 189.92% in 2023 and surged 178.73% in 2025, its largest moves.
- Tracing ELAN's Interest Coverage Ratio over 5 years: stood at 8.66 in 2022, then soared by 56.07% to 3.8 in 2023, then slumped by 35.59% to 5.16 in 2024, then soared by 89.34% to 0.55 in 2025, then jumped by 1028.23% to 5.11 in 2026.
- Business Quant data shows ELAN's Interest Coverage Ratio at 5.11 in Q1 2026, 0.55 in Q4 2025, and 2.73 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.11 |
| Dec 31, 2025 | -0.55 |
| Sep 30, 2025 | 2.73 |
| Jun 30, 2025 | 2.65 |
| Mar 31, 2025 | 6.00 |
| Dec 31, 2024 | -5.16 |
| Sep 30, 2024 | 1.16 |
| Jun 30, 2024 | -8.11 |
| Mar 31, 2024 | -7.62 |
| Dec 31, 2023 | -3.80 |
| Sep 30, 2023 | -22.00 |
| Jun 30, 2023 | -6.93 |
| Mar 31, 2023 | -6.03 |
| Dec 31, 2022 | -8.66 |
| Sep 30, 2022 | -7.59 |
| Jun 30, 2022 | -6.73 |
| Mar 31, 2022 | -5.56 |
| Dec 31, 2021 | -11.55 |
| Sep 30, 2021 | -10.53 |
| Jun 30, 2021 | -13.13 |